Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma

Published:2016-09 Issue: Volume:60 Page:18-24
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Lu Lixia,Li Jiaxin,Zhao Chong,Xue Wenqiong,Han Fei,Tao Tang,Chang Hui,Jia Weihua,Lu Taixiang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference36 articles.

1. AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?;Ma;Int J Radiation Oncol∗ Biol∗ Phys,2001

2. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China;Chen;Radiother Oncol,2012

3. Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience;Palazzi;Int J Radiation Oncol∗ Biol∗ Phys,2009

4. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series;Lin;Int J Radiation Oncol∗ Biol∗ Phys,2009

5. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma]. Ai zheng= Aizheng=;Zhao;Chin J Cancer,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of integrating tumor volume and plasma Epstein-Barr virus DNA load during sequential chemoradiotherapy for prognostic prediction and therapeutic guidance in high-risk locoregionally advanced nasopharyngeal carcinoma;Oral Oncology;2023-10

2. Nomograms incorporating primary tumor response at mid‐radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma;Head & Neck;2023-05-19

3. The Dynamic Change in Plasma Epstein–Barr Virus DNA Load over a Long-Term Follow-Up Period Predicts Prognosis in Nasopharyngeal Carcinoma;Viruses;2022-12-25

4. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area;Oral Oncology;2022-12

5. Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA;BMC Cancer;2022-08-05